These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 12776197

  • 1. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
    Li YJ, Song R, Korkola JE, Archer MC, Ben-David Y.
    Oncogene; 2003 May 29; 22(22):3452-62. PubMed ID: 12776197
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4.
    Xuan W, Li YJ, Liu G, Ben-David Y, Archer MC.
    Mol Cancer Res; 2009 Mar 29; 7(3):433-42. PubMed ID: 19258414
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y, Thakur A, Sun Y, Wu J, Biliran H, Bollig A, Liao DJ.
    Cancer Res; 2007 Apr 15; 67(8):3698-707. PubMed ID: 17440082
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of anchorage-independent cell growth, adhesion, and cyclin D1 gene expression by a dominant negative mutant of a tyrosine phosphatase.
    Mitra SK, Swarup G.
    Exp Cell Res; 2001 Oct 15; 270(1):32-44. PubMed ID: 11597125
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B.
    Cancer Res; 2007 Apr 01; 67(7):3135-44. PubMed ID: 17409420
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dissociation of ras oncogene-induced gene expression and anchorage-independent growth in a series of somatic cell mutants.
    Feinleib JL, Krauss RS.
    Mol Carcinog; 1996 Jul 01; 16(3):139-48. PubMed ID: 8688149
    [Abstract] [Full Text] [Related]

  • 9. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
    Haag JD, Hsu LC, Newton MA, Gould MN.
    Mol Carcinog; 1996 Nov 01; 17(3):134-43. PubMed ID: 8944073
    [Abstract] [Full Text] [Related]

  • 10. Overcoming the activity of mammary carcinoma suppressor gene in Copenhagen rats by v-H-ras oncogene transfer into mammary epithelial cells in situ.
    Wang B, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN.
    Cancer Res; 1991 Oct 01; 51(19):5298-303. PubMed ID: 1913652
    [Abstract] [Full Text] [Related]

  • 11. Comparative genomics of susceptibility to mammary carcinogenesis among inbred rat strains: role of reduced prolactin signaling in resistance of the Copenhagen strain.
    Ren X, Zhang X, Kim AS, Mikheev AM, Fang M, Sullivan RC, Bumgarner RE, Zarbl H.
    Carcinogenesis; 2008 Jan 01; 29(1):177-85. PubMed ID: 17916903
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene.
    Rao RN, Stamm NB, Otto K, Kovacevic S, Watkins SA, Rutherford P, Lemke S, Cocke K, Beckmann RP, Houck K, Johnson D, Skidmore BJ.
    Oncogene; 1999 Nov 04; 18(46):6343-56. PubMed ID: 10597234
    [Abstract] [Full Text] [Related]

  • 14. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
    Wang BC, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN.
    Cancer Res; 1991 May 15; 51(10):2642-8. PubMed ID: 2021942
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression.
    Shintani M, Okazaki A, Masuda T, Kawada M, Ishizuka M, Doki Y, Weinstein IB, Imoto M.
    Anticancer Res; 2002 May 15; 22(2A):639-47. PubMed ID: 12014632
    [Abstract] [Full Text] [Related]

  • 17. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.
    Houck KA, Michalopoulos GK, Strom SC.
    Oncogene; 1989 Jan 15; 4(1):19-25. PubMed ID: 2783773
    [Abstract] [Full Text] [Related]

  • 18. Progression of hormone-dependent adenocarcinoma cells to hormone-independent spindle carcinoma cells in vitro in a clonal spontaneous rat mammary tumor cell line.
    Nakanishi H, Taylor RM, Chrest FJ, Masui T, Utsumi K, Tatematsu M, Passaniti A.
    Cancer Res; 1995 Jan 15; 55(2):399-407. PubMed ID: 7529136
    [Abstract] [Full Text] [Related]

  • 19. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
    Lovec H, Sewing A, Lucibello FC, Müller R, Möröy T.
    Oncogene; 1994 Jan 15; 9(1):323-6. PubMed ID: 8302597
    [Abstract] [Full Text] [Related]

  • 20. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J, Jiang B, Coffey RJ, Barnard J.
    Mol Cancer Res; 2004 Apr 15; 2(4):233-41. PubMed ID: 15140945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.